Skip Navigation
Skip to contents

JYMS : Journal of Yeungnam Medical Science

Indexed in: ESCI, Scopus, PubMed,
PubMed Central, Embase, CAS, KCI
FREE article processing charge
OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Yeungnam Med Sci > Volume 43; 2026 > Article
Original article
Thoracic and Cardiovascular Surgery
Chest packing with negative pressure for refractory mediastinal bleeding after cardiac surgery: a low-cost, simple technique as an alternative to vacuum-assisted closure systems in a retrospective study
Hunbo Shim1orcid, Seok Soo Lee2orcid, Changseok Jeon3orcid, Tae Hee Won4, Sang-Wan Ryu5, JongHyun Baek6orcid
Journal of Yeungnam Medical Science 2026;43:49.
DOI: https://doi.org/10.12701/jyms.2026.43.49
Published online: July 27, 2026

1Division of Cardiac Surgery, University of Rochester Medical Center, Rochester, NY, USA

2Department of Thoracic and Cardiovascular Surgery, Changwon Hanmaeum Hospital, Changwon Korea

3Department of Thoracic and Cardiovascular Surgery, Incheon Sejong Hospital, Incheon, Korea

4Department of Thoracic and Cardiovascular Surgery, Ewha Womans University Seoul Hospital, Ewha Womans University School of Medicine, Seoul, Korea

5Department of Thoracic and Cardiovascular Surgery, International St. Mary’s Hospital, Incheon, Korea

6Department of Thoracic and Cardiovascular Surgery, Yeungnam University College of Medicine, Daegu, Korea

Corresponding author: JongHyun Baek, MD Department of Thoracic and Cardiovascular Surgery, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea Tel: +82-53-620-3880 • FAX: +82-53-626-8660 • E-mail: yumc2000@yu.ac.kr
• Received: June 24, 2026   • Revised: July 13, 2026   • Accepted: July 22, 2026

© 2026 Yeungnam University College of Medicine, Yeungnam University Institute of Medical Science

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 467 Views
  • 56 Download
  • Background
    Refractory mediastinal bleeding after cardiac surgery occasionally requires temporary open sternum and delayed sternal closure. We evaluated the feasibility and short‑term clinical performance of a modified chest‑gauze suction (c‑GSUC) technique that generates negative pressure using readily available materials.
  • Methods
    We retrospectively reviewed 20 patients who underwent chest packing primarily for refractory bleeding following cardiac or thoracic aorta surgery. After routine drainage placement, gauze sponges were packed around the bleeding sites, and an additional temporary chest tube was positioned over the gauze. The open sternotomy was sealed with an adhesive drape and connected to a standard three-chamber drainage bottle to generate negative pressure and collapse the packed gauze.
  • Results
    The median patient age was 57.0 years, and 19 patients (95.0%) underwent aorta-related procedures. Definitive chest closure was achieved within 2 days in 18 patients (90.0%). One patient (5.0%) required emergent washout for cardiac tamponade during open chest management. One patient (5.0%) developed mediastinitis after closure. Two patients (10.0%) died during hospitalization, one from septic shock and the other from intracranial hemorrhage.
  • Conclusion
    Temporary open sternum with negative‑pressure gauze packing using the c‑GSUC technique was feasible in patients with refractory mediastinal bleeding and was associated with acceptable short‑term outcomes. Although less sophisticated than commercial vacuum-assisted closure systems, this simple and inexpensive approach may be a practical alternative in selected cases.
Open chest and delayed sternal closure following cardiac surgery is a well‑established technique used in patients with unstable hemodynamics and/or refractory mediastinal bleeding. This approach allows selective compression of bleeding points [1] while minimizing interference with diastolic filling [2-5]. Despite the correction of coagulation abnormalities and meticulous surgical hemostasis, refractory mediastinal bleeding remains an unavoidable challenge in cardiac surgery. Previous reports indicate that 2% to 4% of adult patients leave the operating room with an open sternum [6-10] and 2% to 6% require re-exploration for postoperative bleeding [11-16]. Although traditional chest packing can effectively control bleeding with relatively low rates of mediastinitis and acceptable survival, many surgeons are hesitant to leave the sternum open because of concerns about infection, thoracic cage instability, and uncertainty regarding the effectiveness of conventional packing techniques.
Negative pressure-generating devices such as vacuum-assisted closure (VAC) systems, initially developed for managing mediastinitis and sternal wound infections, have recently been used to control mediastinal bleeding and hemodynamic instability in patients with open sternum, with reported reductions in infection rates and improved bleeding control [8].
Traditional chest packing has long been used to treat refractory mediastinal bleeding at our institution. This technique was recently modified and standardized to incorporate negative pressure using simple gauze sponges and a chest tube, with the aim of reproducing the mediastinal compression effects of commercial VAC systems at substantially lower costs. In this study, we evaluated the feasibility and practical performance of this modified chest gauze suction (c-GSUC) technique in patients with refractory mediastinal bleeding after cardiac surgery.
Ethics statement: This study was approved by the Institutional Review Board (IRB) of Ewha University Medical Center (IRB No: 2022 09 035), and the requirement for informed consent was waived.
1. Study cohort and inclusion criteria
A total of 1,650 patients underwent cardiac and/or thoracic aorta surgery at our department between January 2010 and August 2022. Among them, 27 (1.6%) left the operating room with an open chest and were initially screened for inclusion.
Three patients required an open chest solely for hemodynamic compromise without significant bleeding and were excluded to focus on the feasibility of the technique for hemostasis. Two patients who underwent descending thoracic aorta surgery via lateral thoracotomy and two patients with missing data were also excluded. Ultimately, 20 patients who underwent chest packing for uncontrolled coagulopathy after cardiac or thoracic aorta surgery via sternotomy were included in the final analysis.
2. Decision-making process for implementation of the open chest technique
The surgeon and anesthesiologist jointly determined the presence of refractory bleeding based on clinical presentation and laboratory findings after heparinization reversal [17]. The following criteria were considered: (1) persistent blood pooling in the operative field, despite no identifiable source of surgical bleeding and ongoing correction of coagulopathy. (2) Blood exceeding 600 mL was purified from the cell saver reservoir canister. Notably, at our institution, each 500 mL of hemodiluted collection in the cell saver canister yields approximately 120 mL of purified erythrocytes. This can vary depending on the degree of dilution. (3) Failing to maintain hemoglobin levels corresponding to transfusion quantities by the third serial hemoglobin evaluation (evaluated at 30-minute intervals). For example, based on the average weight of Korean adults (50–70 kg), a transfusion of 250 mL of packed erythrocytes is expected to increase hemoglobin levels by 1.0 g/dL.
3. Technical details of the chest gauze suction technique
At our hospital, a novel chest packing technique was protocolized and unanimously used by all surgeons for the management of patients who required the open chest technique during the study period (Fig. 1). After inserting the usual drainage tubes, a minimum number of gauze sponges were packed around the incision and suture sites (anastomosis sites of the arch vessels and aortotomy, left atriotomy, right atriotomy, and cannulation sites) to prevent packed gauze-related tamponade. Without a sternal bridge, two to three additional gauzes were used to cover the entire surgical field. A 32-French regular chest tube was then placed on top of the covered gauze, and the chest tube side hole was covered with additional gauze. The open wound was sealed with an adhesive drape film (Ioban; 3M Healthcare, St. Paul, MN, USA) to ensure airtightness. The temporary chest tube used to collapse the packed gauze was then connected to a separate drainage bottle, distinct from other chest tubes. A traditional three-chamber underwater seal drain system with a wet suction control chamber was used for all chest bottles. This suction, controlled by the level of water in the suction control chamber, was typically set at -20 cmH2O to collapse the packed gauze (Fig. 1F).
4. Management during open chest
All patients were sedated, immobilized, and mechanically ventilated in the intensive care unit (ICU) until chest closure. Coagulopathy correction was the primary goal of patient management as all patients underwent chest packing for refractory bleeding. Blood products were transfused according to the patients’ coagulation profiles. Prophylactic intravenous vancomycin was administered after the primary surgery. If any infection was detected on culture tests, appropriate antibiotics were administered after consultation with microbiologists. Once the output from all chest tubes subsided, the patients were transferred to the operating room for washout and chest closure. In addition, for patients with hemodynamic instability caused by cardiac tamponade due to ongoing bleeding, bedside clot evacuation was performed as deemed necessary.
5. Estimations of initiation and theoretical maintenance costs
Material costs for c‑GSUC were compared with hypothetical costs of applying a VAC system in the same patient group, with emphasis on the expenses required at initiation. As the technique was performed as part of the primary surgery, no additional labor costs were attributed. In most patients, the duration of open chest maintenance was short; therefore, ICU labor costs were excluded.
The c‑GSUC materials included gauze sponges, chest tubes, adhesive drape film, polyvinyl chloride tubing, connectors, and drainage bottles. Hypothetical VAC costs included gauze sponges, a disposable VAC system kit (tubing and covering film), and drainage canisters. The VAC pressure generator was excluded as it is a reusable hospital asset.
Because the duration of c‑GSUC was brief, the direct estimation of daily maintenance costs was not feasible. To provide a practical comparison, we applied daily maintenance costs reported in a prior study using USA hospital data [18], which estimated an average VAC maintenance cost of $111.2 per day and $4.3 per day for gauze‑based suction techniques. These unit costs were multiplied by each patient’s open chest duration to estimate the theoretical total maintenance costs. Given that both cost values were derived deterministically from the same duration variable, these calculations represent illustrative cost estimates rather than independently observed or statistically comparable data.
6. Data collection and statistics
Patient demographics, preoperative laboratory values, intraoperative variables, transfusion data, and postoperative outcomes were extracted from electronic medical records. Continuous variables that demonstrated non-normal distribution on the Shapiro-Wilk test were summarized using the median and interquartile range (IQR). Because VAC and c‑GSUC cost estimates were deterministically derived by multiplying each patient’s open chest duration by fixed daily unit costs, no formal statistical comparison was performed for cost analysis. Cost values are presented as illustrative estimates. All statistical analyses were performed using R ver. 4.4.3 (R Foundation for Statistical Computing, Vienna, Austria).
1. Patient demographics and preoperative conditions
The patient characteristics are summarized in Table 1. The median patient age was 57.0 years, and 14 patients (70.0%) were male. Of the 20 patients included in the study, nine had undergone emergency surgeries and 11 underwent elective surgeries.
Six patients (30.0%) were taking aspirin, clopidogrel, or warfarin, and only one patient received dual antiplatelet therapy. According to our institution’s protocol, low-dose aspirin was administered until the day before surgery, and clopidogrel was discontinued at least 5 days before surgery. Warfarin was fully reversed and activated partial thromboplastin time was maintained within 60 to 80 seconds using an intravenous heparin drip in all elective surgeries. Among the nine patients who required emergency surgery, only one (patient #10) received anticoagulation therapy with warfarin. This patient’s international normalized ratio was normalized before the surgery by administering vitamin K and fresh frozen plasma. The anticoagulation laboratory profiles were within the normal range in most patients (Table 2). Nine patients (45.0%) underwent redo surgery at the time of the index surgery.
2. Operative details and chest closure
Thoracic aorta-related surgery was the most performed surgical procedure. A total of 19 patients (95.0%) underwent ascending aorta or ascending aorta/arch surgery. An aortic valve procedure was performed in 14 patients (70.0%). Of these patients, seven (35.0%) underwent the Bentall procedure and three (15.0%) underwent valve-sparing root replacement (David procedure). The median surgery, cardiopulmonary bypass, and myocardial ischemia times were 535, 259, and 199 minutes, respectively. Definitive chest closure was performed by postoperative day 2 in most patients (18 patients, 90.0%) with a median of 1.5 days (IQR, 1.0–2.0 days). These procedures were performed mostly in the operating room (Table 3).
The combined procedures in one patient were counted separately for each procedure. Since the aortic valve is manipulated in valve-sparing aortic root replacement and the Bentall procedure, these aortic valve manipulations were counted as aortic valve surgeries. Massive volumes of blood products were transfused during the surgeries, and coagulopathy was aggressively corrected during the open chest in the ICU (Table 4).
3. Comparison of estimated procedure costs
The calculated charges for the one‑time application of c‑GSUC amounted to $33.2, whereas the estimated initiation cost for VAC was $79.2. When applying daily maintenance cost values reported in prior literature [18], the theoretical median total cost was $166.8 (IQR, $111.2–$222.4) for VAC and $6.3 ($4.3–$8.5) for c‑GSUC. Because both cost values were derived deterministically by multiplying each patient’s open chest duration by the fixed daily unit costs, these figures represent illustrative cost estimates rather than statistically comparable data (Table 5).
4. Hospital course after definitive chest closure
The median durations of ICU and hospital stay were 6 days and 17.5 days, respectively. Wound dehiscence and possible mediastinitis developed in only one patient after delayed chest closure (patient #17). This patient underwent a Bentall procedure for prosthetic valve endocarditis and was administered antibiotics for continuing bacteremia after the surgery. The wound was repaired with simple revision, but subsequent computed tomography revealed a suspicious shadow, possibly an infected fluid collection. Fortunately, the patient was successfully treated with antibiotics.
Two patients had mediastinitis (patients #8 and #18); however, they had pre-existing mediastinitis as a complication of previous interventions when they were transferred from another hospital. Patient #18 experienced wound dehiscence accompanied by purulent discharge 22 days after chest closure. The wound was explored and the VAC system was used for 10 days. The patient was discharged after wound closure. Patient #8 died of septic shock, and together with patient #19, who died of intracranial hemorrhage, were counted as two in-hospital mortalities.
Three patients (15.0%) experienced significant pericardial effusion. Only one of them developed hemodynamically unstable cardiac tamponade with an open chest and required emergent chest washout due to a hematoma compressing the heart (patient #3). However, two patients required separate pericardiostomy for pericardial effusion after chest closure (patients #8 and #15). One patient (patient #2) developed complete atrioventricular block, and a permanent pacemaker was implanted on postoperative day 11 (Table 6).
5. Clinical outcomes after discharge
In addition to the two in-hospital deaths, one patient (#3) was sent to a rehabilitation facility because of a cerebrovascular accident for which follow-up information could not be obtained.
Of the 17 patients who were discharged, 12 experienced no events within 1 year after discharge (patients #1, 2, 4–7, 9, 11, 16–18, and 20), including patients #17 and #18, who underwent wound revision prior to discharge. Patient #10 developed right carotid artery stenosis 8 months after discharge, necessitating admission to the neurology step-down unit for medical intervention. This patient did not have any procedure-related complications 1 year postoperatively.
Three patients (#12, #13, and #14) were lost to follow-up after their 3-month follow-up visits, and one patient (#15) was lost to follow-up 8 months postoperatively. No complications were observed in these patients during the observed follow-up period.
Persistent mediastinal bleeding after cardiopulmonary bypass is a life-threatening complication of cardiac surgery. Various factors including technical issues, increased heparin activity, hemodilution, hypothermia, increased fibrinolytic activity, and platelet dysfunction have been associated with increased blood loss after cardiac surgery [19-22]. Despite coagulopathy correction and the use of surgical or chemical hemostasis, continuous bleeding may occur in some cases. In these patients, a temporarily open sternum and cardiac structural compression can be lifesaving. Institutions use different protocols for maintaining an open sternum, including gauze packing, temporary skin closure without sternal approximation, and silicone membrane coverage [2,23-25]. However, concerns remain regarding traditional techniques, including infection risk, thoracic cage instability requiring more invasive respiratory support, potential right ventricular injury from sternal edges, and skin injury due to frequent dressing changes [26]. These concerns contribute to a high threshold for leaving the operating room with an open sternum. To address these limitations, negative pressure wound therapy (NPWT) using VAC systems, which was initially developed for sternal wound infections and mediastinitis, has been increasingly used instead of traditional gauze packing [8,26].
The main rationale for NPWT in an open sternum is to avoid wound contamination through an airtight seal while stabilizing the thoracic cage [26]. However, NPWT must be used cautiously in patients with hemodynamic instability because excessive negative pressure may impair diastolic filling. Eckardt et al. [23] reported outcomes in a mixed population in which persistent mediastinal bleeding was managed using both traditional gauze packing and NPWT. In their protocol, traditional packing was used for cardiogenic shock, whereas NPWT was generally used for coagulopathy. As hemodynamic instability and coagulopathy often coexist, traditional packing may be less effective in controlling coagulopathic bleeding. Lowering negative pressure can provide selective mediastinal compression without causing cardiac tamponade. In a subsequent study from the same institution, NPWT nearly replaced traditional packing and was associated with improved early survival (61% vs. 44% at 6 months) and lower re‑exploration rates (29% vs. 44%) [8].
Before the introduction of commercial VAC systems, Sjögren et al. [1] described a simple negative pressure technique using surgical sponges and chest tubes placed in both pleural cavities to control coagulopathic bleeding. This fundamental concept is similar to that of commercial VAC systems. Our method resembles theirs but uses a separate temporary large-bore chest tube placed directly over the covered gauze to provide more direct suction. The negative pressure generated was sufficient to collapse the packed gauze and enhance selective compression without exerting excessive pressure on the surrounding structures.
Our technique is an adaptation of conventional chest packing and remains rudimentary compared to commercial VAC systems because of the absence of a monitoring console and limited ability to regulate negative pressure. Using a standard three‑chamber drainage bottle, negative pressure typically ranges from 5 to 20 cmH2O, although dry suction systems can generate up to 40 cmH2O [27]. As shown in Fig. 1, a negative pressure of 20 cmH2O was sufficient to collapse the gauze without endangering mediastinal organs. Unlike VAC therapy for infected wounds, which requires prolonged use and precise pressure monitoring, our technique is used for short durations (generally 1–2 days) and gauze collapse can be visually confirmed.
The affordability and accessibility of this technique provide additional advantages. Materials for c‑GSUC cost $33.2, compared with $79.2 for VAC. If multiple dressing changes are required, the cost difference would increase substantially. Using previously published daily maintenance costs [18], the theoretical daily cost of VAC is approximately $111.2, compared with $4.3 for gauze‑based suction. These values represent illustrative cost estimates, as they are derived from fixed daily unit costs rather than from independently observed expenditures.
In our cohort, three patients were diagnosed with mediastinitis. However, two had pre‑existing mediastinitis before being transferred to our institution. Only one patient developed new mediastinitis after delayed chest closure, and the causality with the open sternum was unclear.
Previously reported mortality rates for patients undergoing open sternum and delayed closure range from 20% to 45%, largely reflecting cohorts with hemodynamic instability, mechanical circulatory support, and complex combined procedures [6-9,23,26]. In contrast, only two patients (10.0%) in our study died before discharge. This difference should be interpreted with caution because our cohort consisted primarily of patients with refractory coagulopathic bleeding rather than those with hemodynamic instability. Therefore, the comparison of mortality with historical cohorts is indirect and should be considered hypothesis-generating rather than confirmatory. Most patients in our study underwent chest closure on the day after open sternum application, which is consistent with the short-term indication for mediastinal negative pressure.
This study has limitations owing to its retrospective design and small sample size. The cohort included only patients who underwent this technique for refractory bleeding and not for hemodynamic instability. Because refractory bleeding and hemodynamic instability often coexist, a selection bias may be present. Hemodynamic instability may also confound the assessment of hemostasis in small cohorts. This descriptive study was designed to evaluate feasibility rather than efficacy. Additional multicenter data, including all indications for open sternum, are necessary to evaluate the technique using risk-adjusted or subgroup analyses.
This study describes our experience with a protocolized chest packing technique that generates negative pressure to control refractory mediastinal bleeding. This technique is accessible, inexpensive, and may offer meaningful cost advantages over commercial VAC systems. Although less sophisticated than VAC, it may be a feasible alternative for selected patients.

Conflicts of interest

No potential conflict of interest relevant to this article was reported.

Funding

None.

Author contributions

Conceptualization: HS, THW, SWR, JB; Data curation: HS, SSL, CJ, THW, JB; Formal analysis: HS, CJ; Investigation, Project administration: HS; Methodology: HS, JB; Resources: HS, CJ, THW, SWR; Software, Visualization: HS, SSL; Supervision: JB; Writing-original draft: HS; Writing-review & editing: HS, JB.

Fig. 1.
Chest packing with simple gauze and an ordinary chest tube, which generates negative pressure on the mediastinum. The steps used in this technique are as follows. (A) Gauze is sparsely packed around the bleeding area and possible bleeding focus. (B) The entire field is covered with additional gauze to mask the structures. (C) A 32-French regular chest tube is placed on top of the covered gauze. (D) Chest tube side holes are covered using additional gauze. (E) The open wound is sealed with an adhesive drape film (Ioban, 3M Healthcare, St. Paul, MN, USA). (F) The chest tubes are connected to a regular bottle with negative pressure (20 cmH2O) to keep the packed gauze compressed.
jyms-2026-43-49f1.jpg
Table 1.
Patient characteristics
No. Age (yr) Sex OPs Preoperative conditions Previous OP (n) Anticoagulation PLT (×103/μL) Hb (g/dL) Hct (%) aPTT (sec) PT (INR) OP time (min) CPB time (min) ACC time (min) Postoperative chest output (mL) ICU (day) GW (day) Complications
1 72 M AVR, MVR IE (Elective) 0 Aspirin 138 10.6 29.4 39.0 1.17 540 245 200 740 7 16 None
2 54 M MVR, Bentall IE (Elective) 2 None 270 11.2 33.2 39.0 1.19 585 320 300 2,430 10 35 AV block
3 46 M AVR, AscAoR, CABG (Elective) 0 Aspirin + clopidogrel 233 11.5 33.9 32.0 1.05 570 330 160 740 17 22 CVA, pericardial effusion, ARF
4 56 F AVR, TVP, AscAoR (Elective) 0 None 212 10.3 31.6 39.0 1.05 510 210 90 1,400 8 20 CVA
5 38 M MVR, TVP, CABG Behcet (Elective) 2 Warfarin 195 12.8 37.6 51.7 1.41 560 300 258 1,030 5 19 None
6 64 F AscAoR (Emergency) 1 None 120 14.2 42.7 36.4 1.22 520 220 137 2,300 6 11 None
7 47 M Bentall, CABG Behcet (Elective) 2 Aspirin 170 10.3 29.7 48.3 2.41 825 420 225 940 13 28 None
8 68 M Bentall, CABG IE, mediastinitis (Elective) 1 None 117 10.8 32.9 51.9 2.22 720 432 268 3,590 25 25 Pericardial effusion, AKI, wound dehiscence, death
9 76 F AscAoR, total arch Emergency 0 None 345 10.4 31.6 35.6 1.32 350 189 111 2,280 6 18 Pleural effusion
10 61 M Bentall IE (Emergency) 1 Warfarin 188 8.7 25.3 52.4 2.1 525 282 216 630 3 43 None
11 58 F AscAoR (Emergency) 0 None 70 13.2 42.9 31.1 1.02 360 136 76 760 3 12 None
12 53 M Bentall, AscAoR, Total arch (Elective) 1 None 126 10.1 30.9 34.6 1.13 460 218 137 1,305 3 13 None
13 56 M VSRR, AscAoR Marfan (Emergency) 0 None 234 13.4 40.3 48.0 1.13 420 221 196 2,050 5 17 None
14 50 F VSRR, AscAoR (Emergency) 0 None 236 13.9 42.6 33.7 1.02 340 213 164 680 2 9 Pleural effusion
15 70 F AVR, AscAoR (Emergency) 0 None 168 11.1 33.5 40.6 1.23 530 258 202 560 6 17 Pericardial effusion
16 44 M AscAoR, total arch, CABG (Emergency) 0 None 146 13.6 39.9 39.1 1.23 1,020 481 239 2,760 6 17 AKI
17 86 M Bentall IE, (Elective) 1 Aspirin 138 11.6 33.8 40.4 1.12 660 308 199 6,472 8 13 AKI, mediastinitis, wound dehiscence, sepsis
18 65 M Bentall Behcet, mediastinitis, (Elective) 2 None 291 9.8 28.9 51.5 1.33 780 344 242 2,062 21 41 Wound dehiscence
19 64 M AscAoR, total arch (Emergency) 0 None 105 15.9 47.3 44.2 1.7 470 240 165 1,610 47 53 CVA, AKI, pneumonia, death
20 42 M MVR, VSRR, AscAoR Marfan (Elective) 0 None 159 9.1 26.6 30.0 0.97 660 260 234 660 4 15 CVA

M, male; F, female; OP, operation; PLT, platelet count; Hb, hemoglobin; Hct, hematocrit; aPTT, activated partial thromboplastin time; PT, prothrombin time; INR, international normalized ratio; CPB, cardiopulmonary bypass; ACC, aortic cross-clamp; ICU, intensive care unit; GW, general ward; AVR, aortic valve replacement; MVR, mitral valve replacement; IE, infective endocarditis; AV block, atrioventricular block; AscAoR, ascending aorta replacement; CABG, coronary artery bypass grafting; TVP, tricuspid valvuloplasty; CVA, cerebrovascular accident; ARF, acute renal failure; AKI, acute kidney injury; VSRR, valve-sparing root replacement.

Table 2.
Patient demographics and preoperative details
Characteristic Data
Demographics
 No. of patients 20
 Age (yr) 57.0 (47.8–67.3)
 Male sex 14 (70.0)
Anticoagulation
 Aspirin 4 (20.0)
 Clopidogrel 1 (5.0)
 Warfarin 2 (10.0)
Clinical condition at the time of surgery
 No. of previous surgeries via sternotomy
  0 11 (55.0)
  1 5 (25.0)
  2 4 (20.0)
 Infective endocarditis 5 (25.0)
 Connective tissue disease 5 (25.0)
Preoperative laboratory findings
 Platelet counts (×103/µL) 169.0 (129.0–233.8)
 Hemoglobin (g/dL) 11.5 (10.0–13.8)
 Hematocrit (%) 33.5 (30.3–40.0)
 WBC count (/μL) 8,515.0 (6,722.5–13,297.5)
 aPTT (sec) 39.0 (35.3–48.0)
 PT (INR) 1.0 (1.0–1.0)

Values are presented as number, median (interquartile range), or number (%).

WBC, white blood cell; aPTT, activated partial thromboplastin time; PT, prothrombin time.

Table 3.
Table caption
Variable Data
Indexed procedure, CABG 4 (20.0)
Valve operation
 Aortic 14 (70.0)
 Mitral 4 (20.0)
 Tricuspid 2 (10.0)
Aortic surgery 19 (95.0)
Perfusion details, min
 Operation time 535.0 (462.5–660.0)
 CPB time 259.0 (218.5–327.5)
 ACC time 199.5 (142.8–237.8)
Duration of open chest management, day 1.5 (1.0–2.0)
 1 10 (50.0)
 2 8 (40.0)
 3 2 (10.0)
Chest closure location
 Operating room 18 (90.0)
 Intensive care unit 2 (10.0)

Values are presented as number (%) or median (interquartile range).

CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; ACC, aortic cross-clamp.

Table 4.
Bleeding characteristics and transfusion details
Variable Data
Bleeding sitesa)
 General ooze from an unlocalized area 14 (70.0)
 Needle holes in the suture line 8 (40.0)
 Posterior to the anastomotic site 3 (15.0)
Intraoperative transfusion (mL)
 pRBC 1,120.0 (800.0–1,600.0)
 Platelet concentrate 640.0 (430.0–800.0)
 FFP 720.0 (360.0–1,215.0)
 Cryoprecipitate 320.0 (140.0–400.0)
Postoperative chest tube output (mL) 1,352.5 (740.0–2,295.0)
Postoperative transfusion (mL)
 pRBC 1,105.0 (445.0–1,537.5)
 Platelet concentrate 220.0 (0.0–442.5)
 FFP 550.0 (79.8–1,170.0)
 Cryoprecipitate 0.0 (0.0–180.0)

Values are presented as median (interquartile range) or number (%).

pRBC, packed red blood cells; FFP, fresh frozen plasma.

a)Bleeding focus can overlap in incidence.

Table 5.
Estimated theoretical costs for c-GSUC vs. VAC
Cost (US$) c-GSUC VAC
Initial cost 33.2 79.2
Daily maintenance cost 4.3 111.2
Total theoretical cost 6.3 (4.3–8.5) 166.8 (111.2–222.4)

Values are presented as cost or median (interquartile range).

c-GSUC, chest-gauze suction; VAC, vacuum-assisted closure; IQR, interquartile range.

Table 6.
Postoperative outcomes
Variable Data
Duration of stay (day)
 Intensive care unit 6.0 (4.3–12.3)
 Total hospital stay 17.5 (13.5–27.3)
Death 2 (10.0)
Other complications
 Cerebrovascular accident 5 (25.0)
 Pericardial effusion 3 (15.0)
 Pleural effusion 2 (10.0)
 Acute kidney injury 5 (25.0)
 Atrioventricular block 1 (5.0)
 Mediastinitis 3 (15.0)a)
 Wound dehiscence 3 (15.0)a)
 Pneumonia 2 (10.0)
 Sepsis 2 (10.0)

Values are presented as median (interquartile range) or number (%).

a)Two patients with mediastinitis and wound dehiscence at the time of surgery were transferred to our institution.

  • 1. Sjögren J, Gustafsson R, Koul B, Ingemansson R. Selective mediastinal tamponade to control coagulopathic bleeding. Ann Thorac Surg 2003;75:1311–3.ArticlePubMed
  • 2. Riahi M, Tomatis LA, Schlosser RJ, Bertolozzi E, Johnston DW. Cardiac compression due to closure of the median sternotomy in open heart surgery. Chest 1975;67:113–4.ArticlePubMed
  • 3. Gielchinsky I, Parsonnet V, Krishnan B, Silidker M, Abel RM. Delayed sternal closure following open-heart operation. Ann Thorac Surg 1981;32:273–7.ArticlePubMed
  • 4. Furnary AP, Magovern JA, Simpson KA, Magovern GJ. Prolonged open sternotomy and delayed sternal closure after cardiac operations. Ann Thorac Surg 1992;54:233–9.ArticlePubMed
  • 5. Christenson JT, Maurice J, Simonet F, Velebit V, Schmuziger M. Open chest and delayed sternal closure after cardiac surgery. Eur J Cardiothorac Surg 1996;10:305–11.ArticlePubMed
  • 6. Boeken U, Assmann A, Mehdiani A, Akhyari P, Lichtenberg A. Open chest management after cardiac operations: outcome and timing of delayed sternal closure. Eur J Cardiothorac Surg 2011;40:1146–50.ArticlePubMed
  • 7. Anderson CA, Filsoufi F, Aklog L, Farivar RS, Byrne JG, Adams DH. Liberal use of delayed sternal closure for postcardiotomy hemodynamic instability. Ann Thorac Surg 2002;73:1484–8.ArticlePubMed
  • 8. Bakaeen FG, Haddad O, Ibrahim M, Pasadyn SR, Germano E, Mok S, et al. Advances in managing the noninfected open chest after cardiac surgery: negative-pressure wound therapy. J Thorac Cardiovasc Surg 2019;157:1891–903.e9.ArticlePubMed
  • 9. Wong JK, Joshi DJ, Melvin AL, Aquina CT, Archibald WJ, Lidder AK, et al. Early and late outcomes with prolonged open chest management after cardiac surgery. J Thorac Cardiovasc Surg 2017;154:915–24.ArticlePubMed
  • 10. Crestanello JA, Greason K, Elsisy M, Lahr B, Bagameri G, Daly R, et al. Impact of time to chest closure on early and late survival in adults with delayed sternal closure. Eur J Cardiothorac Surg 2023;63:ezad044. ArticlePubMedPDF
  • 11. Karthik S, Grayson AD, McCarron EE, Pullan DM, Desmond MJ. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg 2004;78:527–34.ArticlePubMed
  • 12. Ranucci M, Bozzetti G, Ditta A, Cotza M, Carboni G, Ballotta A. Surgical reexploration after cardiac operations: why a worse outcome? Ann Thorac Surg 2008;86:1557–62.ArticlePubMed
  • 13. Mehta RH, Sheng S, O'Brien SM, Grover FL, Gammie JS, Ferguson TB, et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes 2009;2:583–90.ArticlePubMed
  • 14. Ruel M, Chan V, Boodhwani M, McDonald B, Ni X, Gill G, et al. How detrimental is reexploration for bleeding after cardiac surgery? J Thorac Cardiovasc Surg 2017;154:927–35.ArticlePubMed
  • 15. Pasrija C, Ghoreishi M, Whitman G, Ad N, Alejo DE, Holmes SD, et al. Mitigating the risk: transfusion or reoperation for bleeding after cardiac surgery. Ann Thorac Surg 2020;110:457–63.ArticlePubMed
  • 16. De La Porte VM, De Meyer GR, Schepens T, Verbrugghe W, Laga S, Allegaert M, et al. Reoperation for bleeding after cardiac surgery. Acta Chir Belg 2022;122:312–20.ArticlePubMed
  • 17. Dyke C, Aronson S, Dietrich W, Hofmann A, Karkouti K, Levi M, et al. Universal definition of perioperative bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg 2014;147:1458–63.e1.ArticlePubMed
  • 18. Kim JJ, Franczyk M, Gottlieb LJ, Song DH. Cost-effective alternative for negative-pressure wound therapy. Plast Reconstr Surg Glob Open 2017;5:e1211. ArticlePubMedPMC
  • 19. Bartoszko J, Karkouti K. Managing the coagulopathy associated with cardiopulmonary bypass. J Thromb Haemost 2021;19:617–32.ArticlePubMedPDF
  • 20. Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P. Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery: a retrospective review. Eur J Anaesthesiol 2014;31:317–26.ArticlePubMed
  • 21. Höfer J, Fries D, Solomon C, Velik-Salchner C, Ausserer J. A snapshot of coagulopathy after cardiopulmonary bypass. Clin Appl Thromb Hemost 2016;22:505–11.ArticlePubMedPDF
  • 22. Ranucci M, Baryshnikova E, Ciotti E, Ranucci M, Silvetti S; Surgical and Clinical Outcome REsearch (SCORE) Group. Hemodilution on cardiopulmonary bypass: thromboelastography patterns and coagulation-related outcomes. J Cardiothorac Vasc Anesth 2017;31:1588–94.ArticlePubMed
  • 23. Eckardt JL, Wanek MR, Udeh CI, Neuner EA, Fraser TG, Attia T, et al. Evaluation of prophylactic antibiotic use for delayed sternal closure after cardiothoracic operation. Ann Thorac Surg 2018;105:1365–9.ArticlePubMed
  • 24. Yabrodi M, Hermann JL, Brown JW, Rodefeld MD, Turrentine MW, Mastropietro CW. Minimization of surgical site infections in patients with delayed sternal closure after pediatric cardiac surgery. World J Pediatr Congenit Heart Surg 2019;10:400–6.ArticlePubMedPDF
  • 25. Doğan A, Ada ET, Türköz R. Using eye speculum as a sternal retractor for delayed sternal closure after pediatric heart surgery. J Card Surg 2021;36:2179–81.ArticlePubMedPDF
  • 26. Fleck T, Kickinger B, Moidl R, Waldenberger F, Wolner E, Grabenwoger M, et al. Management of open chest and delayed sternal closure with the vacuum assisted closure system: preliminary experience. Interact Cardiovasc Thorac Surg 2008;7:801–4.ArticlePubMed
  • 27. Zisis C, Tsirgogianni K, Lazaridis G, Lampaki S, Baka S, Mpoukovinas I, et al. Chest drainage systems in use. Ann Transl Med 2015;3:43.ArticlePubMedPMC

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      Figure
      • 0
      Chest packing with negative pressure for refractory mediastinal bleeding after cardiac surgery: a low-cost, simple technique as an alternative to vacuum-assisted closure systems in a retrospective study
      Image
      Fig. 1. Chest packing with simple gauze and an ordinary chest tube, which generates negative pressure on the mediastinum. The steps used in this technique are as follows. (A) Gauze is sparsely packed around the bleeding area and possible bleeding focus. (B) The entire field is covered with additional gauze to mask the structures. (C) A 32-French regular chest tube is placed on top of the covered gauze. (D) Chest tube side holes are covered using additional gauze. (E) The open wound is sealed with an adhesive drape film (Ioban, 3M Healthcare, St. Paul, MN, USA). (F) The chest tubes are connected to a regular bottle with negative pressure (20 cmH2O) to keep the packed gauze compressed.
      Chest packing with negative pressure for refractory mediastinal bleeding after cardiac surgery: a low-cost, simple technique as an alternative to vacuum-assisted closure systems in a retrospective study
      No. Age (yr) Sex OPs Preoperative conditions Previous OP (n) Anticoagulation PLT (×103/μL) Hb (g/dL) Hct (%) aPTT (sec) PT (INR) OP time (min) CPB time (min) ACC time (min) Postoperative chest output (mL) ICU (day) GW (day) Complications
      1 72 M AVR, MVR IE (Elective) 0 Aspirin 138 10.6 29.4 39.0 1.17 540 245 200 740 7 16 None
      2 54 M MVR, Bentall IE (Elective) 2 None 270 11.2 33.2 39.0 1.19 585 320 300 2,430 10 35 AV block
      3 46 M AVR, AscAoR, CABG (Elective) 0 Aspirin + clopidogrel 233 11.5 33.9 32.0 1.05 570 330 160 740 17 22 CVA, pericardial effusion, ARF
      4 56 F AVR, TVP, AscAoR (Elective) 0 None 212 10.3 31.6 39.0 1.05 510 210 90 1,400 8 20 CVA
      5 38 M MVR, TVP, CABG Behcet (Elective) 2 Warfarin 195 12.8 37.6 51.7 1.41 560 300 258 1,030 5 19 None
      6 64 F AscAoR (Emergency) 1 None 120 14.2 42.7 36.4 1.22 520 220 137 2,300 6 11 None
      7 47 M Bentall, CABG Behcet (Elective) 2 Aspirin 170 10.3 29.7 48.3 2.41 825 420 225 940 13 28 None
      8 68 M Bentall, CABG IE, mediastinitis (Elective) 1 None 117 10.8 32.9 51.9 2.22 720 432 268 3,590 25 25 Pericardial effusion, AKI, wound dehiscence, death
      9 76 F AscAoR, total arch Emergency 0 None 345 10.4 31.6 35.6 1.32 350 189 111 2,280 6 18 Pleural effusion
      10 61 M Bentall IE (Emergency) 1 Warfarin 188 8.7 25.3 52.4 2.1 525 282 216 630 3 43 None
      11 58 F AscAoR (Emergency) 0 None 70 13.2 42.9 31.1 1.02 360 136 76 760 3 12 None
      12 53 M Bentall, AscAoR, Total arch (Elective) 1 None 126 10.1 30.9 34.6 1.13 460 218 137 1,305 3 13 None
      13 56 M VSRR, AscAoR Marfan (Emergency) 0 None 234 13.4 40.3 48.0 1.13 420 221 196 2,050 5 17 None
      14 50 F VSRR, AscAoR (Emergency) 0 None 236 13.9 42.6 33.7 1.02 340 213 164 680 2 9 Pleural effusion
      15 70 F AVR, AscAoR (Emergency) 0 None 168 11.1 33.5 40.6 1.23 530 258 202 560 6 17 Pericardial effusion
      16 44 M AscAoR, total arch, CABG (Emergency) 0 None 146 13.6 39.9 39.1 1.23 1,020 481 239 2,760 6 17 AKI
      17 86 M Bentall IE, (Elective) 1 Aspirin 138 11.6 33.8 40.4 1.12 660 308 199 6,472 8 13 AKI, mediastinitis, wound dehiscence, sepsis
      18 65 M Bentall Behcet, mediastinitis, (Elective) 2 None 291 9.8 28.9 51.5 1.33 780 344 242 2,062 21 41 Wound dehiscence
      19 64 M AscAoR, total arch (Emergency) 0 None 105 15.9 47.3 44.2 1.7 470 240 165 1,610 47 53 CVA, AKI, pneumonia, death
      20 42 M MVR, VSRR, AscAoR Marfan (Elective) 0 None 159 9.1 26.6 30.0 0.97 660 260 234 660 4 15 CVA
      Characteristic Data
      Demographics
       No. of patients 20
       Age (yr) 57.0 (47.8–67.3)
       Male sex 14 (70.0)
      Anticoagulation
       Aspirin 4 (20.0)
       Clopidogrel 1 (5.0)
       Warfarin 2 (10.0)
      Clinical condition at the time of surgery
       No. of previous surgeries via sternotomy
        0 11 (55.0)
        1 5 (25.0)
        2 4 (20.0)
       Infective endocarditis 5 (25.0)
       Connective tissue disease 5 (25.0)
      Preoperative laboratory findings
       Platelet counts (×103/µL) 169.0 (129.0–233.8)
       Hemoglobin (g/dL) 11.5 (10.0–13.8)
       Hematocrit (%) 33.5 (30.3–40.0)
       WBC count (/μL) 8,515.0 (6,722.5–13,297.5)
       aPTT (sec) 39.0 (35.3–48.0)
       PT (INR) 1.0 (1.0–1.0)
      Variable Data
      Indexed procedure, CABG 4 (20.0)
      Valve operation
       Aortic 14 (70.0)
       Mitral 4 (20.0)
       Tricuspid 2 (10.0)
      Aortic surgery 19 (95.0)
      Perfusion details, min
       Operation time 535.0 (462.5–660.0)
       CPB time 259.0 (218.5–327.5)
       ACC time 199.5 (142.8–237.8)
      Duration of open chest management, day 1.5 (1.0–2.0)
       1 10 (50.0)
       2 8 (40.0)
       3 2 (10.0)
      Chest closure location
       Operating room 18 (90.0)
       Intensive care unit 2 (10.0)
      Variable Data
      Bleeding sitesa)
       General ooze from an unlocalized area 14 (70.0)
       Needle holes in the suture line 8 (40.0)
       Posterior to the anastomotic site 3 (15.0)
      Intraoperative transfusion (mL)
       pRBC 1,120.0 (800.0–1,600.0)
       Platelet concentrate 640.0 (430.0–800.0)
       FFP 720.0 (360.0–1,215.0)
       Cryoprecipitate 320.0 (140.0–400.0)
      Postoperative chest tube output (mL) 1,352.5 (740.0–2,295.0)
      Postoperative transfusion (mL)
       pRBC 1,105.0 (445.0–1,537.5)
       Platelet concentrate 220.0 (0.0–442.5)
       FFP 550.0 (79.8–1,170.0)
       Cryoprecipitate 0.0 (0.0–180.0)
      Cost (US$) c-GSUC VAC
      Initial cost 33.2 79.2
      Daily maintenance cost 4.3 111.2
      Total theoretical cost 6.3 (4.3–8.5) 166.8 (111.2–222.4)
      Variable Data
      Duration of stay (day)
       Intensive care unit 6.0 (4.3–12.3)
       Total hospital stay 17.5 (13.5–27.3)
      Death 2 (10.0)
      Other complications
       Cerebrovascular accident 5 (25.0)
       Pericardial effusion 3 (15.0)
       Pleural effusion 2 (10.0)
       Acute kidney injury 5 (25.0)
       Atrioventricular block 1 (5.0)
       Mediastinitis 3 (15.0)a)
       Wound dehiscence 3 (15.0)a)
       Pneumonia 2 (10.0)
       Sepsis 2 (10.0)
      Table 1. Patient characteristics

      M, male; F, female; OP, operation; PLT, platelet count; Hb, hemoglobin; Hct, hematocrit; aPTT, activated partial thromboplastin time; PT, prothrombin time; INR, international normalized ratio; CPB, cardiopulmonary bypass; ACC, aortic cross-clamp; ICU, intensive care unit; GW, general ward; AVR, aortic valve replacement; MVR, mitral valve replacement; IE, infective endocarditis; AV block, atrioventricular block; AscAoR, ascending aorta replacement; CABG, coronary artery bypass grafting; TVP, tricuspid valvuloplasty; CVA, cerebrovascular accident; ARF, acute renal failure; AKI, acute kidney injury; VSRR, valve-sparing root replacement.

      Table 2. Patient demographics and preoperative details

      Values are presented as number, median (interquartile range), or number (%).

      WBC, white blood cell; aPTT, activated partial thromboplastin time; PT, prothrombin time.

      Table 3. Table caption

      Values are presented as number (%) or median (interquartile range).

      CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; ACC, aortic cross-clamp.

      Table 4. Bleeding characteristics and transfusion details

      Values are presented as median (interquartile range) or number (%).

      pRBC, packed red blood cells; FFP, fresh frozen plasma.

      Bleeding focus can overlap in incidence.

      Table 5. Estimated theoretical costs for c-GSUC vs. VAC

      Values are presented as cost or median (interquartile range).

      c-GSUC, chest-gauze suction; VAC, vacuum-assisted closure; IQR, interquartile range.

      Table 6. Postoperative outcomes

      Values are presented as median (interquartile range) or number (%).

      Two patients with mediastinitis and wound dehiscence at the time of surgery were transferred to our institution.


      JYMS : Journal of Yeungnam Medical Science
      TOP